Tassani , Peter ; Schad , Hubert ; Schreiber , Christian et alin Journal of Cardiothoracic and Vascular Anesthesia ( 2007 ) , 21(2 ) , 174 - 178OBJECTIVE : The systemic inflammatory response to cardiopulmonary bypass ( CPB ) possibly increases microvascular permeability to plasma proteinsleadingto capillary leak syndrome
a drug or a condition(passive) caused byyour capillary leak syndrome
cytokine release in DS(passive) caused bycapillary leak syndrome
Maripa virus in French Guiana(passive) triggered byMeersseman W. Capillary leak - syndrome
References of " Schreiber , Christian " Tassani , Peter ; Schad , Hubert ; Schreiber , Christian et al in Journal of Cardiothoracic and Vascular Anesthesia ( 2007 ) , 21(2 ) , 174 - 178 OBJECTIVE : The systemic inflammatory response to cardiopulmonary bypass ( CPB ) possibly increases microvascular permeability to plasma proteinsleadingto capillary leak syndrome
that endothelial cell damage due to administration of high doses of follicle - stimulating hormone and luteinizing hormone during pituitary suppression with a gonadotropin - releasing hormone analogcausesa capillary leak syndrome
while receiving off - label high doses of another C1 inhibitor product ( up to 500 units / kgto preventcapillary leak syndrome
Douglas L. / Intraperitoneal photodynamic therapycausesa capillary - leak syndrome
Drugs including some interleukins , some monoclonal antibodies , and gemcitabinecan also causecapillary leak syndrome
doxorubicin therapy in a patient with myeloma multiplex Department of Cardiology and Internal Diseases , Military Institute of the Health Services , Warszawa , Poland Cardiol J 17:88 - 91(passive) caused bycapillary leak syndrome
doxorubicin therapy in a patient with myeloma multiplex | Krzesiński | Cardiology Journal Paweł Krzesiński , Robert Wierzbowski , Grzegorz Gielerak , Janusz Hałka , Oxana Matysiak , Paweł Smurzyński Cardiol J 2010;17(1):88 - 91(passive) caused bycapillary leak syndrome
Patients with known risk factors for thrombotic events ( including indwelling catheters ) should be monitored units / kgto preventcapillary leak syndrome
fluid that accumulates in the tissues of the body(passive) is caused byCapillary leak syndrome
capillary hyperpermeability resulting in a shift of fluid and protein into the interstitial space(passive) is caused byCapillary leak syndrome ( CLS
the shift of fluid and protein from the intravascular space to the interstitial space as a result of repetitive episodes of capillary hyperpermeability(passive) 's caused bySystemic capillary leak syndrome ( SCLS
an upper respiratory tract infection(passive) may be triggered bySystemic capillary leak syndrome
a systemic inflammatory response or a fluid shift caused by hypoalbuminemia [ 19,20(passive) caused bycapillary leakage syndrome
IL-6 is knownto causecapillary leakage syndrome
In this condition , the blood coagulation contact system and the complement system are activatedleadingto a capillary leak syndrome
a direct toxic effect on the endothelial cells of the pulmonary capillariescausesa capillary leak syndrome ( 22,29
Clarkson et al in 19601(passive) was discovered bySystemic capillary leak syndrome
endothelial damage due to circulating mediators , neutrophils and platelets and disseminated intravascular coagulation leading to microthrombi(passive) caused bya severe capillary leak syndrome
Walter D. Y. Quan , Maria Rosana Ramirez , Chris B Taylor , Francine Marie Quan , Mikhail Vinogradov , Paul Walker High - dose bolus or continuous infusion interleukin-2-based therapycan causecapillary leak syndrome
10 % ( Eurax ) and accumulation viagra online canadian pharmacy of pulmonary aspiration ( ie , mast cell degranulationleadingto capillary leak syndrome
immune procedure mobile activation.[eleven ] Harm to the endothelial layer of blood vessels brought on by these inflammatory mediatorsmay resultin capillary leak syndrome
a compartment syndrome of both lower legs and a forearmcausesa compartment syndrome of both lower legs and a forearm
to multiple organ failure , shock and even death.[1][2 ] Greipp PRmay leadto multiple organ failure , shock and even death.[1][2 ] Greipp PR
in hypotension and pulmonary edemaresultingin hypotension and pulmonary edema
to severe hypotensionwill leadto severe hypotension
to hypotension , hemoconcentration , and hypoalbuminemialeadsto hypotension , hemoconcentration , and hypoalbuminemia
to intravascular fluid escaping from the bloodstream and damaging the patient 's vital organsleadsto intravascular fluid escaping from the bloodstream and damaging the patient 's vital organs
to significant side effectscan leadto significant side effects
with serious consequencesresultedwith serious consequences
in hypotension and organ damageresultingin hypotension and organ damage
to acute renal failure.[1leadingto acute renal failure.[1
from interleukin-2 therapy in mice Títuloresultingfrom interleukin-2 therapy in mice Título
from extravasation of plasma proteins and fluid into ex - travascular space and a loss of vascular toneresultingfrom extravasation of plasma proteins and fluid into ex - travascular space and a loss of vascular tone
to multiorgan dysfunction that requires skill and ex- perience to administer the maximum number of doses tolerated while avoid- ing life - threatening toxicitiesmay leadto multiorgan dysfunction that requires skill and ex- perience to administer the maximum number of doses tolerated while avoid- ing life - threatening toxicities
to massive fluid retention and hypotensionleadsto massive fluid retention and hypotension
to fluid imbalance , hypotension and , ultimately ... organ failurecan leadto fluid imbalance , hypotension and , ultimately ... organ failure
to multiorgan dysfunction that requires skill and ex- perience to administer the maximum number of doses tolerated while avoid- ing binary options daily forum los angeles toxicitiesmay leadto multiorgan dysfunction that requires skill and ex- perience to administer the maximum number of doses tolerated while avoid- ing binary options daily forum los angeles toxicities
to peripheral edema , hypotension and renal insufficiencyleadingto peripheral edema , hypotension and renal insufficiency
in ascites or pulmonary edemaresultingin ascites or pulmonary edema
to severe pulmonary edemaleadsto severe pulmonary edema
to acute renal failure in patients with acute promyelocytic leukemialeadingto acute renal failure in patients with acute promyelocytic leukemia
hypotension and reduced organ perfusion ( possibly severe and resulting in deathcauseshypotension and reduced organ perfusion ( possibly severe and resulting in death
in hypotension and reduced circulation of blood in the organs , which may be severe and can result in deathcan resultin hypotension and reduced circulation of blood in the organs , which may be severe and can result in death
to acute pulmonary edema.10can leadto acute pulmonary edema.10
tohypotension , hemoconcentration , and hypoalbuminemialeadstohypotension , hemoconcentration , and hypoalbuminemia
to a coma and eventual deathcan leadto a coma and eventual death
to death in 3 patientsledto death in 3 patients
to swelling of soft tissue and pulmonary edemacan leadto swelling of soft tissue and pulmonary edema
to fluid extravasation into tissue hypotension and oliguria all of which are reversible with no long - term sequelaeleadsto fluid extravasation into tissue hypotension and oliguria all of which are reversible with no long - term sequelae
significant non - cardiogenic pulmonary oedemacausingsignificant non - cardiogenic pulmonary oedema
in non - cardiogenic pulmonary edema and extravascular fluid shiftresultingin non - cardiogenic pulmonary edema and extravascular fluid shift
in peripheral edema , noncardiogenic pulmonary edema , and pleural effusionsresultingin peripheral edema , noncardiogenic pulmonary edema , and pleural effusions
to hemorrhage , shock , end - organ failure and deathcan leadto hemorrhage , shock , end - organ failure and death
to death in 2 of 3 patients treated at that doseleadingto death in 2 of 3 patients treated at that dose
to the development of the clinical signs of TSS.3 TSST-1 and staphylococcal enterotoxinsleadingto the development of the clinical signs of TSS.3 TSST-1 and staphylococcal enterotoxins
fluid retention and potentially peripheral oedema , pericardial or pleural effusions which necessitate drug withdrawalcausingfluid retention and potentially peripheral oedema , pericardial or pleural effusions which necessitate drug withdrawal
his lungs to fill with watercausedhis lungs to fill with water
alsoleadsalso
his lungs to fill with fluidcausedhis lungs to fill with fluid
in severe lower limb deformitymay resultin severe lower limb deformity